findmyKOL
Clinical trialNCT01037231CompletedPhase 2/PHASE3Interventional

Phase 2/3 Oxabact Study

SponsorOxTheraEnrollment36Primary Hyperoxaluria
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering urinary oxalate levels in patients with primary hyperoxaluria.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • University Children'S Hospital (division of Pediatric Nephrology)

    Cologne, Germany

Netherlands
  • Academy Medical Center, University of Amsterdam

    Amsterdam, Netherlands

United States
  • Mayo Clinic (department of Pediatric Nephrology)

    Rochester, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Oxalobacter formigenesPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2009
Primary completion
31 Jan 2011
Completion
31 Jan 2011
Last update posted
15 May 2013
Registered enrollment
36
Registry id
NCT01037231
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.